Summit Therapeutics Inc (SMMT)
4.515
+0.02
(+0.56%)
USD |
NASDAQ |
May 16, 16:00
4.515
0.00 (0.00%)
After-Hours: 20:00
Summit Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2022 | -9.72K% |
June 30, 2022 | -7.14K% |
March 31, 2022 | -8.56K% |
December 31, 2021 | -10.80K% |
September 30, 2021 | -1.50K% |
June 30, 2021 | -42.84K% |
March 31, 2021 | -9.11K% |
December 31, 2020 | -7.32K% |
September 30, 2020 | -9.80K% |
June 30, 2020 | -8.99K% |
March 31, 2020 | -1.89K% |
October 31, 2019 | -5.67K% |
Date | Value |
---|---|
July 31, 2019 | -4.09K% |
April 30, 2019 | -1.62K% |
January 31, 2019 | -169.8% |
October 31, 2018 | -1.21K% |
July 31, 2018 | 70.17% |
April 30, 2018 | -150.8% |
January 31, 2018 | -307.2% |
October 31, 2017 | -32.84% |
July 31, 2017 | -69.07% |
April 30, 2017 | -275.5% |
January 31, 2017 | -304.6% |
October 31, 2016 | -795.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-42.84K%
Minimum
Jun 2021
-1.50K%
Maximum
Sep 2021
-9.80K%
Average
-8.56K%
Median
Mar 2022
Profit Margin (Quarterly) Benchmarks
I-MAB | -- |
Retractable Technologies Inc | -0.51% |
BioCardia Inc | -15.94K% |
Alpine Immune Sciences Inc | -254.8% |
Axsome Therapeutics Inc | -91.14% |